Item 1(a). | Name of Issuer: |
ProQR Therapeutics N.V. (the “Issuer”)
Item 1(b). | Address of Issuer’s Principal Executive Offices: |
Zernikedreef 9, 2333 CK Leiden, The Netherlands
Item 2(a). | Name of Person Filing: |
Item 2(b). | Address of Principal Business Office or, if none, Residence: |
(i) Invus Public Equities, L.P. (“Invus Public Equities”)
750 Lexington Avenue, 30th Floor, New York, NY 10022
Citizenship: Bermuda limited partnership
(ii) Invus Public Equities Advisors, LLC (“Invus PE Advisors”)
750 Lexington Avenue, 30th Floor, New York, NY 10022
Citizenship: Delaware limited liability company
(iii) Artal Treasury Limited (“Artal Treasury”)
PO Box 265, Suite 6, Borough House, Rue du Pre, St. Peter Port, Guernsey GY1 3QU
Citizenship: Guernsey company
(iv) Artal International S.C.A. (“Artal International”)
Valley Park, 44, Rue de la Vallée,L-2661, Luxembourg
Citizenship: Luxembourg limited partnership
(v) Artal International Management S.A. (“Artal International Management”)
Valley Park, 44, Rue de la Vallée,L-2661, Luxembourg
Citizenship: Luxembourg société anonyme
(vi) Artal Group S.A. (“Artal Group”)
Valley Park, 44, Rue de la Vallée,L-2661, Luxembourg
Citizenship: Luxembourg société anonyme
(vii) Westend S.A. (“Westend”)
Valley Park, 44, Rue de la Vallée,L-2661, Luxembourg
Citizenship: Luxembourg société anonyme
(viii) Stichting Administratiekantoor Westend (the “Stichting”)
Ijsselburcht 3NL-6825 BS Arnhem, The Netherlands
Citizenship: Netherlands foundation
(ix) Mr. Pascal Minne
Rue de l’Industrie 44,B-1000, Bruxelles, Belgium
Citizenship: Belgium
The foregoing persons are hereinafter sometimes collectively referred to as the “Reporting Persons.”